Straitstimes.com header logo

Choose edition

Search

singapore

asia

world

opinion

life

business

sport

Visual

Podcasts

SPH Rewards

STClassifieds

Paid press releases

Advertise with us

FAQs

Contact us

 

Medical research

National Gallery Singapore is Asia’s first Healing Arts Centre of Excellence

The Calm Room is a dedicated space where visitors can rest if they are feeling overstimulated.
The Calm Room is a dedicated space where visitors can rest if they are feeling overstimulated.

Vertex’s gene therapy shows promise in younger children with blood disorders

Gene therapy Casgevy is based on CRISPR gene editing technology, which uses molecular "scissors" to trim faulty parts of genes.
Gene therapy Casgevy is based on CRISPR gene editing technology, which uses molecular "scissors" to trim faulty parts of genes.

New $21m research collaboration to develop treatments for eye diseases

azsonic03 - ST20251203_202527200202. Hester Tan. The Singapore Eye Research Institute and Santen Pharmaceutical will partner on the Santen-SERI Open Innovation Center (SONIC) 2.0, a S$21 million collaboration focusing on glaucoma, ocular surface disease, presbyopia and myopia and advance novel therapeutics that for unmet clinical needs at SNEC Auditorium on 3 December 2025

Top row: (L) Prof Thomas Coffman, Dean of Duke-NUS Medical School, Miss Rie Nakajima, Director of the Board, Chief Operating Officer, Santen and Prof Aung Tin, CEO, Singapore National Eye Centre

Bottom Row: (L) Prof Jodhbir Mehta, Director, Singapore Eye Research Institute and Dr Reza Haque, Head of Ophthalmology Innovation Center, Santen

ST PHOTO: HESTER TAN
azsonic03 - ST20251203_202527200202. Hester Tan. The Singapore Eye Research Institute and Santen Pharmaceutical will partner on the Santen-SERI Open Innovation Center (SONIC) 2.0, a S$21 million collaboration focusing on glaucoma, ocular surface disease, presbyopia and myopia and advance novel therapeutics that for unmet clinical needs at SNEC Auditorium on 3 December 2025

Top row: (L) Prof Thomas Coffman, Dean of Duke-NUS Medical School, Miss Rie Nakajima, Director of the Board, Chief Operating Officer, Santen and Prof Aung Tin, CEO, Singapore National Eye Centre

Bottom Row: (L) Prof Jodhbir Mehta, Director, Singapore Eye Research Institute and Dr Reza Haque, Head of Ophthalmology Innovation Center, Santen

ST PHOTO: HESTER TAN

IMH studies modified PTSD treatment to stop mild depression from worsening

Researchers are studying whether the modified intervention, called Internet-delivered Skills Training in Affective and Interpersonal Regulation or i-STAIR, is effective in managing symptoms of depression.
Researchers are studying whether the modified intervention, called Internet-delivered Skills Training in Affective and Interpersonal Regulation or i-STAIR, is effective in managing symptoms of depression.

Brain implant smaller than grain of salt developed by Cornell, NTU researchers

The microscale optoelectronic tetherless electrode (MOTE) is a wireless neural implant measuring about 300 microns in length and 70 microns in width.
The microscale optoelectronic tetherless electrode (MOTE) is a wireless neural implant measuring about 300 microns in length and 70 microns in width.

Eli Lilly’s daily pill helps people lose 10% of weight in 18 months: Study

According to a study, participants on the highest orforglipron dose of 36mg lost around 10 per cent of their body weight after 72 weeks.
According to a study, participants on the highest orforglipron dose of 36mg lost around 10 per cent of their body weight after 72 weeks.

S’pore’s lung cancer screening study detects cancer in nine participants; all are non-smokers

Lung cancer patient and Solstice participant Kang Kim Choon went for low-dose computed tomography scans as part of the study.
Lung cancer patient and Solstice participant Kang Kim Choon went for low-dose computed tomography scans as part of the study.

Phase 3 of Singapore’s mega gene-mapping effort to enrol at least 400,000 patients

CMG20251114-TayYM02/郑一鸣 /卢慧菁,郭跃男 /National Precision Medicine
Programme Phase Ill Launch:
Strategic Partnerships for
Better Health [Marina One Auditorium,
Level 3]

图说:社会政策统筹部长兼卫生部长王乙康(后排中),见证新加坡精准健康研究所执行董事陈文炜教授(前排左二)与三大公共医疗集群代表签署谅解备忘录,象征全国精准医学计划正式迈入第三阶段。前排左一为国立健保集团医疗委员会主席 (医学研究)薛寒友教授;前排右一起为新保集团副总裁(研究、教育与创新)林顺泰教授及国立大学医学组织副首席执行官 (教育与研究)钟业成教授。
CMG20251114-TayYM02/郑一鸣 /卢慧菁,郭跃男 /National Precision Medicine
Programme Phase Ill Launch:
Strategic Partnerships for
Better Health [Marina One Auditorium,
Level 3]

图说:社会政策统筹部长兼卫生部长王乙康(后排中),见证新加坡精准健康研究所执行董事陈文炜教授(前排左二)与三大公共医疗集群代表签署谅解备忘录,象征全国精准医学计划正式迈入第三阶段。前排左一为国立健保集团医疗委员会主席 (医学研究)薛寒友教授;前排右一起为新保集团副总裁(研究、教育与创新)林顺泰教授及国立大学医学组织副首席执行官 (教育与研究)钟业成教授。

Crispr gene therapy slashes ‘bad’ cholesterol, triglycerides by half in small study

High LDL, the so-called “bad” cholesterol, can cause plaques to build up in artery walls, raising the risk of a heart attack or stroke.
High LDL, the so-called “bad” cholesterol, can cause plaques to build up in artery walls, raising the risk of a heart attack or stroke.

Covid-19 and flu can triple your risk of heart attack: US study

The risk of a heart attack triples within the first few weeks after a Covid-19 infection, the study suggested.
The risk of a heart attack triples within the first few weeks after a Covid-19 infection, the study suggested.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Privacy Policy

Need help? Reach us here.

Advertise with us

Download the app

Get unlimited access to exclusive stories and incisive insights from the ST newsroom
Subscribe Placeholder
MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2025 SPH Media Limited. All rights reserved.